UMIN-CTR History

Name：　　UMIN ID：

Unique ID issued by UMIN	UMIN000038715
Receipt number	R000044135
Scientific Title	Phase II neoadjuvant trial of nab-Paclitaxel+Pertuzumab+Trastuzumab followed by Anthracycline based regimen in patients with operable Her2 positive breast cancer
Date of disclosure of the study information	2019/12/01
Last modified on	2019/11/28 18:43:50

---